The BioJet systemic oral delivery platform is an ingestible drug-device combination developed to prevent drug degradation in the upper gastrointestinal tract and increase drug bioavailability via needleless jet injection in the proximal small intestine following oral administration
Like semaglutide, tirzepatide does not independently affect the safety of donated blood
Novo Nordisk A/ S NYSE: NVO formulated a semaglutide treatment specially designed for obesity when they launched Wegovy in June of 2021
Gallbladder disease including gallstones may occur, particularly with rapid weight loss
Lewis, a Yale-trained board-certified dermatologist in private practice in New York City, also adds that the safety of using a GLP-1 should be determined based on nutritional status, including iron stores, protein stores, hormone recovery, and breastfeeding status
A Structured Debate-Style Cardiothoracic Journal Club for Trainee Acquisition and Application of Seminal Literature